The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Mechanisms of Disease
PreviousPrevious
Volume 354:610-621 February 9, 2006 Number 6
NextNext

The Many Roles of Chemokines and Chemokine Receptors in Inflammation
Israel F. Charo, M.D., Ph.D., and Richard M. Ransohoff, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Animation
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Chemokines (chemotactic cytokines) are small heparin-binding proteins that direct the movement of circulating leukocytes to sites of inflammation or injury. During the eight years since chemokines and chemokine receptors were last reviewed in the Journal,1 a vast expansion in the understanding of chemokine biology has occurred. Originally studied because of their role in inflammation, chemokines and their receptors are now known to play a crucial part in directing the movement of mononuclear cells throughout the body, engendering the adaptive immune response and contributing to the pathogenesis of a variety of diseases. Chemokine receptors are some of the most tractable drug . . . [Full Text of this Article]

Chemokines, Chemokine Receptors, and Innate Immunity

The ELR+ CXC Chemokines

Monocyte Chemoattractant Proteins

CCR7

Movement of Lymphocytes to Skin and Gut

Coreceptors for HIV-1

Inflammatory Diseases

Multiple Sclerosis

Metabolic Disorders

Atherosclerosis

Insulin Resistance and Obesity-Induced Diabetes

Therapeutic Strategies


Source Information

From the Gladstone Institute of Cardiovascular Disease and the Cardiovascular Research Institute, Department of Medicine, University of California, San Francisco — both in San Francisco (I.F.C.); and the Neuroinflammation Research Center, Department of Neurosciences, Lerner Research Institute, the Mellen Center for MS Treatment and Research, and the Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, Cleveland (R.M.R.).

Address reprint requests to Dr. Charo at the Gladstone Institute of Cardiovascular Disease, 1650 Owens St., San Francisco, CA 94158, or at icharo@gladstone.ucsf.edu; or to Dr. Ransohoff at the Department of Neurosciences, NC30, the Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, or at ransohr@ccf.org.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.